2019 CSHL Conference on Biology of Cancer: Microenvironment and Metastasis
Project Number1R13CA239652-01
Contact PI/Project LeaderSTEWART, DAVID J.
Awardee OrganizationCOLD SPRING HARBOR LABORATORY
Description
Abstract Text
Biology of Cancer: Microenvironment & Metastasis
Cold Spring Harbor, New York
September 24 – 28, 2019
ABSTRACT
Cancer is now recognized as an abnormal organ where multiple cell types cooperate during
cancer initiation and metastatic progression. Enormous progress has been made on identifying
genetic, epigenetic and metabolic alterations in tumor cells and characterizing the different cell
types composing a tumor, understanding the mechanisms by which these cell types interact
with each other, developing ways to image the changes in a tumor and exploring therapeutic
opportunities that take into account the non-malignant cells. Thus, there is an emergence of a
need for an integrative approach for controlling cancer. However, most cancer meetings are
organized to focus on one or two aspects of the many aspects of the biology of tumor. The
proposed meeting takes an integrative approach to create a platform and bring together world
leaders in different aspects of cancer biology, genetics, epigenetics, metabolism, signaling,
immunology, diagnostics, and therapeutics to discuss the latest findings and promote dialogue
aimed at solving the chief problems that prevent durable responses in the clinic. We believe that
such an integrative approach will certainly trigger discussions and interactions that cross the
disciplinary borders and find new ways to develop and deliver novel therapeutic strategies for
controlling cancer.
The fifth rendition of this biennial conference will draw participants from academic labs, research
institutes and biotech/pharmaceutical industries, and will include leaders in the field, established
investigators, junior faculty, postdoctoral fellows, graduate students and corporate scientists. To
ensure the presentation of the most cutting edge results many speakers will be chosen based
on the quality of abstracts submitted to the meeting coordinators and session chairs several
months prior to the meeting. To maximize broad participation, efforts have been made to include
outstanding women scientists and scientists from abroad as session chairs and invited
speakers. Each session will be chaired by two leading scientists in the field selected by the
organizers. Oral presentations will be selected from submitted abstracts by the session chairs
in consultation with the organizers. Selected speakers will include graduate students,
postdoctoral fellows and junior faculty aiming for maximal inclusion of young investigators. Of
special importance are the two poster sessions and panel discussion. The poster session
provide an opportunity for many participants to present their work in an atmosphere conducive
to informal discussion and the panel discussion engages thought leaders and the participants
on one highly debated topic on the role played by personalized cancer medicine in improving
cancer treatment. The meeting will be of moderate size and we expect about 300 people to
attend, the vast majority of whom will be presenting a poster or talk.
Public Health Relevance Statement
Biology of Cancer: Microenvironment & Metastasis
Cold Spring Harbor, New York
September 24 – 28, 2019
PROJECT NARRATIVE
Cancer is a heterogeneous disease consisting of evolving neoplastic cells and multiple
non-neoplastic cell types that cooperatively interact to form a tumor during cancer
initiation and metastatic progression. Heterogeneity within tumors underlies disease
progression and resistance to therapies. Recent accomplishments include the
identification of a litany of genetic, epigenetic, and metabolic alterations that are intrinsic
to tumor biology and that represent new therapeutic opportunities. Additionally, a
greater appreciation of the tumor microenvironment has led to the identification of new
factors that promote tumorigenesis such as exosomes, and new ways to harness the
immune system to prevent metastases and promote the clearance of neoplastic cells.
The fifth rendition of this biennial conference will bring together an international group of
scientists who work on these processes to discuss the latest advances in their field.
No Sub Projects information available for 1R13CA239652-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13CA239652-01
Patents
No Patents information available for 1R13CA239652-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13CA239652-01
Clinical Studies
No Clinical Studies information available for 1R13CA239652-01
News and More
Related News Releases
No news release information available for 1R13CA239652-01
History
No Historical information available for 1R13CA239652-01
Similar Projects
No Similar Projects information available for 1R13CA239652-01